Use of Dupilumab to Manage Antibody-Drug Conjugate-Induced Cutaneous Toxicities.
Saved in:
| Title: | Use of Dupilumab to Manage Antibody-Drug Conjugate-Induced Cutaneous Toxicities. |
|---|---|
| Authors: | Nykaza I; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Dusza SW; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Rosenberg JE; Department of Medicine, Weill Cornell Medical College, New York, New York.; Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Iyer G; Department of Medicine, Weill Cornell Medical College, New York, New York.; Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Feld E; Department of Medicine, Weill Cornell Medical College, New York, New York.; Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Chandarlapaty S; Department of Medicine, Weill Cornell Medical College, New York, New York.; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Jhaveri K; Department of Medicine, Weill Cornell Medical College, New York, New York.; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Lacuna K; Department of Medicine, Weill Cornell Medical College, New York, New York.; Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Gajria D; Department of Medicine, Weill Cornell Medical College, New York, New York.; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Bielawa M; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Markova A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Dermatology, Weill Cornell Medical College, New York, New York., Gordon A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Dermatology, Weill Cornell Medical College, New York, New York. |
| Source: | JAMA dermatology [JAMA Dermatol] 2025 Sep 01; Vol. 161 (9), pp. 980-982. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6084 |
|---|---|
| DOI: | 10.1001/jamadermatol.2025.2567 |
